Stocks in news today

has signed a 5-year Strategic Partnership Framework Agreement, and received its first order from Adani Green Energy. This order is for a Balance of System (BOS) package for three Solar Power Projects at one of the World’s largest RE projects at Khavda Renewable Energy Park, Gujarat. This order involves supply of goods and onsite services with total order valued at around Rs 1,381 crore excluding taxes. The company is currently executing around 6 GW in the Khavda region with around 5 GW scheduled to be completed in this fiscal. With this project of 1 GW, the company continues to maintain a dominant position in the Gujarat region. With this order win, the company has now achieved more than Rs 6,450 crore of order inflows this fiscal. has secured an order worth around Rs 217 crore from ONGC for supply of seamless pipes in oil & gas sector. The order is to be executed over next few quarters as per customer’s requirement. has secured United States Food and Drug Administration’s (USFDA) approval for Armlupeg (pegfilgrastim-unne) 6 mg/0.6 mL injection for subcutaneous use in a single-dose prefilled syringe, as biosimilar to Neulasta (pegfilgrastim) 6 mg/0.6 mL injection. The product will be manufactured at the company’s Biotech facility in Pune, which was inspected by the USFDA prior to approval. Armlupeg is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia. has received an order from renowned customer engaged in the business of owning, developing and operating renewable power projects in India, for supply of 140MW solar modules in Financial Year 2025-26.